Cargando…

New Insights on the Emerging Genomic Landscape of CXCR4 in Cancer: A Lesson from WHIM

Deciphering the molecular alterations leading to disease initiation and progression is currently crucial to identify the most relevant targets for precision therapy in cancer patients. Cancers express a complex chemokine network influencing leucocyte infiltration and angiogenesis. Moreover, malignan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Scala, Stefania, D’Alterio, Crescenzo, Milanesi, Samantha, Castagna, Alessandra, Carriero, Roberta, Farina, Floriana Maria, Locati, Massimo, Borroni, Elena Monica
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349554/ https://www.ncbi.nlm.nih.gov/pubmed/32260318 http://dx.doi.org/10.3390/vaccines8020164

Ejemplares similares

Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom’s Macroglobulinemia
por: Milanesi, Samantha, et al.
Publicado: (2020)

Reduced G protein signaling despite impaired internalization and β-arrestin recruitment in patients carrying a CXCR4(Leu317fsX3) mutation causing WHIM syndrome
por: Kumar, Rajesh, et al.
Publicado: (2023)

Genotype–phenotype correlations in WHIM syndrome: a systematic characterization of CXCR4(WHIM) variants
por: Zmajkovicova, Katarina, et al.
Publicado: (2022)

WHIM Syndrome-linked CXCR4 mutations drive osteoporosis
por: Anginot, Adrienne, et al.
Publicado: (2023)

A novel CXCR4-targeted near-infrared (NIR) fluorescent probe (Peptide R-NIR750) specifically detects CXCR4 expressing tumors
por: Santagata, Sara, et al.
Publicado: (2017)

CXCR4 expression affects overall survival of HCC patients whereas CXCR7 expression does not
por: Neve Polimeno, Maria, et al.
Publicado: (2015)

Inhibition of stromal CXCR4 impairs development of lung metastases
por: D’Alterio, Crescenzo, et al.
Publicado: (2012)

Targeting CXCR4 reverts the suppressive activity of T-regulatory cells in renal cancer
por: Santagata, Sara, et al.
Publicado: (2017)

CXCR4/CXCL12/CXCR7 axis is functional in neuroendocrine tumors and signals on mTOR
por: Circelli, Luisa, et al.
Publicado: (2016)

WHIM Syndrome With a Novel CXCR4 Variant in a Korean Child
por: Shin, Dong Woo, et al.
Publicado: (2017)

Whims of Hysteria
Publicado: (1885)

CXCR4-CXCL12-CXCR7 and PD-1/PD-L1 in Pancreatic Cancer: CXCL12 Predicts Survival of Radically Resected Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties
por: Vacchini, Alessandro, et al.
Publicado: (2018)

Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer
por: Cioffi, Michele, et al.
Publicado: (2015)

CXCL12/CXCR4-Axis Dysfunctions: Markers of the Rare Immunodeficiency Disorder WHIM Syndrome
por: Bachelerie, Françoise
Publicado: (2010)

Preclinical Development of a Novel Class of CXCR4 Antagonist Impairing Solid Tumors Growth and Metastases
por: Portella, Luigi, et al.
Publicado: (2013)

Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients
por: García-Cuesta, Eva M., et al.
Publicado: (2022)

Adaptive Immunodeficiency in WHIM Syndrome
por: Majumdar, Shamik, et al.
Publicado: (2018)

A novel CXCR4 antagonist counteracts paradoxical generation of cisplatin-induced pro-metastatic niches in lung cancer
por: Bertolini, Giulia, et al.
Publicado: (2021)

A chemotaxis model to explain WHIM neutrophil accumulation in the bone marrow of WHIM mouse model
por: Yip, Ai Kia, et al.
Publicado: (2019)

Mesenchymal Stem/Stromal Cells Overexpressing CXCR4(R334X) Revealed Enhanced Migration: A Lesson Learned from the Pathogenesis of WHIM Syndrome
por: Bidkhori, Hamid Reza, et al.
Publicado: (2021)

PB1938: 4WHIM: EVALUATING MAVORIXAFOR, AN ORAL CXCR4 ANTAGONIST, IN PATIENTS WITH WHIM SYNDROME VIA A GLOBAL PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL WITH OPEN-LABEL EXTENSION
por: Dale, D. C., et al.
Publicado: (2022)

Characterization of a new WHIM syndrome mutant reveals mechanistic differences in regulation of the chemokine receptor CXCR4
por: Luo, Jiansong, et al.
Publicado: (2021)

P793: SCREENING OF NATURALLY OCCURRING CXCR4 VARIANTS FOR IDENTIFICATION OF NOVEL PATHOGENIC MUTATIONS FOR WHIM SYNDROME
por: Pawar, S., et al.
Publicado: (2022)

Pandemic puppies bought on a whim
Publicado: (2020)

CXCL12 loaded-dermal filler captures CXCR4 expressing melanoma circulating tumor cells
por: Ieranò, Caterina, et al.
Publicado: (2019)

Case Report: A Novel CXCR4 Mutation in a Chinese Child With Kawasaki Disease Causing WHIM Syndrome
por: Ma, Xiaopeng, et al.
Publicado: (2022)

S180: RESULTS OF A PHASE 3 TRIAL OF AN ORAL CXCR4 ANTAGONIST, MAVORIXAFOR, FOR TREATMENT OF PATIENTS WITH WHIM SYNDROME
por: Badolato, Raffaele, et al.
Publicado: (2023)

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)

Targeting CXCR4 potentiates anti-PD-1 efficacy modifying the tumor microenvironment and inhibiting neoplastic PD-1
por: D’Alterio, Crescenzo, et al.
Publicado: (2019)

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Biological Role of Tumor/Stromal CXCR4-CXCL12-CXCR7 in MITO16A/MaNGO-OV2 Advanced Ovarian Cancer Patients
por: D’Alterio, Crescenzo, et al.
Publicado: (2022)

Control of Cytoskeletal Dynamics by β-Arrestin1/Myosin Vb Signaling Regulates Endosomal Sorting and Scavenging Activity of the Atypical Chemokine Receptor ACKR2
por: Vacchini, Alessandro, et al.
Publicado: (2020)

AMD3100 is a potent antagonist at CXCR4(R334X), a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome
por: McDermott, David H, et al.
Publicado: (2011)

Variability in Immunohistochemical Detection of Programmed Death Ligand 1 (PD-L1) in Cancer Tissue Types
por: Scognamiglio, Giosuè, et al.
Publicado: (2016)

Impaired Recruitment of Grk6 and β-Arrestin2 Causes Delayed Internalization and Desensitization of a WHIM Syndrome-Associated CXCR4 Mutant Receptor
por: McCormick, Peter J., et al.
Publicado: (2009)

Drug Development for Maternal Health Cannot Be Left to the Whims of the Market
Publicado: (2008)

Familial occurrence of warts, hypogammaglobulinemia, infections, and myelokathexis (WHIM) syndrome
por: Siedlar, Maciej, et al.
Publicado: (2008)

Chromothriptic cure of WHIM syndrome: Implications for bone marrow transplantation
por: McDermott, David H, et al.
Publicado: (2015)

Multicenter Experience of Hematopoietic Stem Cell Transplantation in WHIM Syndrome
por: Laberko, Alexandra, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8h8oktvid690g9gqg9f19badv0